EU Advocate General Opines That Seeking Injunctions On FRAND-Encumbered SEPs May Constitute an Abuse of Dominance
|
|
- Horace Hawkins
- 5 years ago
- Views:
Transcription
1 NOVEMBER 17-22, 2014 WRITTEN BY KENNETH H. MERBER EDITED BY KOREN W. WONG-ERVIN The views expressed in this e-bulletin are the views of the author alone. In this Issue: EU Advocate General Opines That Seeking Injunctions on FRAND-Encumbered SEPs May Constitute an Abuse of Dominance IEEE Seeks DOJ Approval of Patent Policy Changes Court Holds Non-Cash Settlement Provisions May Constitute Payments Under Actavis FTC Commissioner Wright Says Avoided Litigation Costs Are An Inappropriate Benchmark for Evaluating Reverse-Payment Settlements ipad Cover Antitrust Claims Dismissed STANDARD-ESSENTIAL PATENTS EU Advocate General Opines That Seeking Injunctions On FRAND-Encumbered SEPs May Constitute an Abuse of Dominance On November 20, 2014, EU Advocate General Melchior Wathelet issued an opinion advising the Court of Justice of the European Union to find that seeking an injunction for infringement of a FRAND-encumbered standard-essential patent (SEP) without first making an offer on FRAND terms constitutes an abuse of dominance in violation of Article 102 of the Treaty on the Functioning of the European Union. The Court of Justice has been asked to clarify the ability of an SEP-holder to seek an injunction under EU competition law by a German court presiding over a dispute between Huawei and ZTE. The Advocate General s opinion is not binding on the Court, but is typically followed.
2 The Opinion concludes that the actions of both parties to the negotiation of a FRAND royalty are relevant in determining whether seeking an injunction is an abuse of dominance. In particular, before seeking an injunction an SEP-holder must provide a written offer for a licence on FRAND terms that contains all the terms normally included in a licence in the sector in question, in particular the precise amount of the royalty and the way in which that amount is calculated. (Opinion 85.) Upon receiving that offer, the potential licenses must respond in a diligent and serious manner to the offer made by the SEP-holder, including by promptly submit[ting] to the SEP-holder, in writing, a reasonable counter-offer relating to the clauses with which it disagrees. (Id. 88.) Seeking a judicial determination of the royalty would be consistent with the potential licensee s obligations, but the SEP-holder could legitimately request assurance of payment during such proceeding, such as a bank guarantee or escrow account. (Id. 93.) In addition, the licensee can challenge both validity and infringement of the patent even after concluding a license. (Id. at ) If an SEP-holder seeks an injunction despite the willingness of the potential licensee to negotiate a FRAND royalty, that would amount to an abuse of dominance. (Id. at Conclusion 1.) Opinion of Advocate General Wathelet, Case C 170/13, Huawei Technologies Co., Ltd. v. ZTE Corp., (Nov. 20, 2014), available at Ryan Davis, EU Court Adviser Sets Plan For Essential Patent Injunctions, LAW360 (Nov. 20, 2014), available at IEEE Seeks DOJ Approval of Patent Policy Changes According to reports from MLex, the Institute of Electrical and Electronics Engineers Standards Association (IEEE) has asked the Antitrust Division of the U.S. Department of Justice (DOJ) to review proposed changes to its patent policy. IEEE develops the ubiquitous Wi-Fi (802.11) standard, among others. In August, it preliminarily approved changes to its patent policy that would clarify the terms of the licensing commitments required from standard-setting participants. The changes provide that essential patent owners cannot seek injunctions, must license all interested parties regardless of their position in the distribution chain, and must calculate reasonable royalties on the smallest salable unit containing the patented technology rather than the full end product. The changes will only take effect upon receipt of the DOJ s business review letter, and subsequent adoption by the organization s Board of Governors. Source: Leah Nylen, IEEE Seeks Review By DOJ On Changes To Intellectual Property Rights Policy, MLEX (Nov. 21, 2014), available at
3 PAY-FOR-DELAY SETTLEMENTS Court Holds Non-Cash Settlement Provisions May Constitute Payments Under Actavis On November 17, 2014, a federal district court in California refused to dismiss antitrust claims brought against pharmaceutical companies that make Lidoderm. According to the allegations, the generic drug manufacturer Watson Pharmaceuticals was paid to delay entry by Endo Pharmaceuticals (a distributor of Lidoderm) and Teikoku Seiyaku (a manufacturer of Lidoderm). Under the terms of the settlement, Watson received free Lidoderm to sell, and was permitted to begin sales of its generic product prior to the expiration of the patent, with 7.5 months of sales before any other authorized generic could enter. The plaintiffs alleged that under these provisions Endo and Teikoku Seiyaku had paid Watson over $200 million to delay entry $96 million in the form of free product and $170 million through the 7.5 month no authorized generic provision. (Order at 1.) Defendants argued that Actavis only applied to cash payments, and that antitrust liability could not attach because the agreement allowed Watson to enter prior to the expiration of the patent. (Id. at 13.) The court rejected both arguments. First, it held that Actavis applies to non-cash payments when courts are able to calculate [the payments ] value. (Id. at 18.) Provision of free product was straightforward to value, and the plaintiffs proposed valuation of the no authorized generic provision based on an FDA study and sales records was not overly complicated, and plausible. (Id. at ) Second, the court held that Watson s entry prior to the expiration of the patent did not preclude a finding that the agreement was anticompetitive. (Id. at 15.) The court explained that Watson s early sales of Lidoderm were required to be at the same prices charged by Endo, and therefore did not increase competition, while its subsequent generic sales were also made at supracompetitive prices due to the agreement to delay introduction of an authorized generic. (Id. at ) Accordingly, the court refused to dismiss the antitrust claims. However, the court held that the no authorized generic provision should be evaluated under the rule of reason, and dismissed plaintiffs per se claim. (Id. at 27.) Order, United Food and Commercial Workers Local 1776 v. Teikoku Pharm USA, No. 14- md (N.D. Cal. Nov. 17, 2014) available at assets.law360news.com/ /597118//mnt/rails_cache/https-ecf-cand-uscourts-govdoc pdf Kurt Orzeck, Pharmas Can t Nix Lidoderm MDL Over $170M Pay-For-Delay Deals, LAW360 (Nov. 18, 2014) available at -3-
4 FTC Commissioner Wright Says Avoided Litigation Costs Are An Inappropriate Benchmark for Evaluating Reverse- Payment Settlements Speaking at the ABA Section of Antitrust Law s Intellectual Property Committee s Annual Fall Networking Event, FTC Commissioner Joshua Wright, in response to a question about pay-for-delay settlements, explained his view that litigation costs are an inappropriate benchmark for evaluating reverse payments under the rule of reason. Referring to a paper that he wrote with Bruce Kobayashi, Judge Douglas Ginsburg, and Joanna Tsai, Wright explained that the recent economic analysis of reverse-payment settlements is based upon a monopoly-to-duopoly model that assumes a single generic entrant, which is incomplete and ignores critical institutional details. Instead, according to Wright et al, in realty, entry by multiple firms can follow the invalidation of a patent. Instead of obtaining duopoly profits for the duration of the life of the patent, as assumed in the monopoly-toduopoly model, the generic entrant that successfully challenges the validity of the brand s patent obtains duopoly profits only for a period limited to a 180-day period of exclusivity. After this period, both the brand and the generic entrant that successfully invalidated the patent in litigation obtain only the lower profits associated with free entry. Accounting for this critical institutional detail results in a broader settlement range than under the monopoly-to-duopoly model that yields robust incentives for the brand and generic entrant to settle cases. In short, taking into account the institutional reality that a successful patent challenge results in free entry rather than duopoly implies consumer welfare-increasing settlements can occur with very large payments, including payments several times greater than avoided litigation costs. Moreover, incorporating multiple serial entrants also decouples the litigation-adjusted expected value of the patent and the consumer welfare standard and weakens the relationship between patent strength and the size of the settlement. FTC Commissioner says non-cash payments will fall within Actavis ABA IP Committee meeting PaRR (Nov. 20, 2014), available at Bruce H. Kobayashi, Joshua D. Wright, Douglas H. Ginsburg, and Joanna Tsai, Actavis and Multiple ANDA Entrants: Beyond the Temporary Duopoly (Oct. 8, 2014), available at LITIGATION ipad Cover Antitrust Claims Dismissed On November 17, 2014, a federal court in Seattle dismissed claims by Hard 2 Find Accessories (H2F) that Apple had conspired with Amazon to exclude low-priced competitors. H2F sold ipad covers through Amazon s marketplace, but its listings were removed after Apple complained that the -4-
5 covers were counterfeit. Amazon subsequently terminated H2F s seller privileges altogether, which drove H2F out of business. According to H2F, this constituted a conspiracy to shutter Apple s lowcost competitors. The court rejected all claims against Apple because Apple was alleged to have excluded H2F solely by complaining of potential trademark infringement to Amazon, which is protected petitioning activity under the Noerr-Pennington doctrine. (Order at 3.) The court also noted that allegations of this single interaction were insufficient to support a conspiracy claim even if Apple s conduct had not been immune from suit, as it had already found with respect to the antitrust claims against Amazon in a prior order. (Id. at 5-6.) Order, Hard 2 Find Accessories, Inc. v. Amazon.com, Inc., No. 14-cv-950 (W.D. Wash. Nov. 17, 2014). Brandon Lowrey, Apple, Amazon Quickly Core Suit Over ipad Cover Sales, LAW360 (Nov. 17, 2014) available at -5-
APLI Antitrust & Licensing Issues Panel: SEP Injunctions
APLI Antitrust & Licensing Issues Panel: SEP Injunctions Robert D. Fram Covington & Burling LLP Advanced Patent Law Institute Palo Alto, California December 11, 2015 1 Disclaimer The views set forth on
More informationFederal Circuit Provides Guidance on Methodologies for Calculating FRAND Royalty Rates, Vacating the Jury Award in Ericsson v.
In this Issue: WRITTEN BY COURTNEY J. ARMOUR AND KOREN W. WONG-ERVIN EDITED BY KOREN W. WONG-ERVIN The views expressed in this e-bulletin are the views of the authors alone. DECEMBER 1-6, 2014 Federal
More informationDOJ Issues Favorable BRL on Proposed Revisions to IEEE s Patent Policy
In this Issue: WRITTEN BY BRENDAN J. COFFMAN AND KOREN W. WONG-ERVIN DOJ Issues Favorable BRL on Proposed Revisions to IEEE s Patent Policy FEBRUARY 2-7, 2015 EC to Closely Watch Proposed Revisions to
More informationAntitrust and Intellectual Property
and Intellectual Property July 22, 2016 Rob Kidwell, Member Antitrust Prohibitions vs IP Protections The Challenge Harmonizing U.S. antitrust laws that sanction the illegal use of monopoly/market power
More informationTHE ACTAVIS INFERENCE: THEORY AND PRACTICE
THE ACTAVIS INFERENCE: THEORY AND PRACTICE Aaron Edlin, Scott Hemphill, Herbert Hovenkamp & Carl Shapiro ABSTRACT In FTC v. Actavis, Inc., the Supreme Court considered reverse payment settlements of patent
More informationCourt Dismisses NPE s Group Boycott Claims Against RPX, Motorola, Samsung, and Others
THIS WEEK S CONTRIBUTING AUTHOR IS M. BRINKLEY TAPPAN EDITED BY KOREN W. WONG-ERVIN JANUARY 21-25, 2013 PATENTS Court Dismisses NPE s Group Boycott Claims Against RPX, Motorola, Samsung, and Others On
More informationGoogle Settles with FTC Over SEPs; FTC Votes to Close Investigation Into Google s Search-Related Practices
December 24, 2012 - January 4, 2013 THIS WEEK S CONTRIBUTING AUTHOR IS FLAVIA FORTES EDITED BY KOREN W. WONG-ERVIN PATENTS Google Settles with FTC Over SEPs; FTC Votes to Close Investigation Into Google
More informationLaw in the Global Marketplace: Intellectual Property and Related Issues FRAND in Europe: Huawei vs ZTE decision
Law in the Global Marketplace: Intellectual Property and Related Issues FRAND in Europe: Huawei vs ZTE decision Hosted by: Overview Why the decision is important What does the Huawei vs ZTE decision say?
More informationFederal Court Dismisses Claims Against NPE for Allegedly Fraudulently Enforcing Its Patents; Upholds Breach of Contract and Promissory Estoppel Claims
FEBRUARY 4-8, 2013 WRITTEN BY KOREN W. WONG-ERVIN PATENTS Federal Court Dismisses Claims Against NPE for Allegedly Fraudulently Enforcing Its Patents; Upholds Breach of Contract and Promissory Estoppel
More informationCourt Approves 24.3 Million in Attorneys' Fees in Pay-For- Delay Litigation
WRITTEN BY SHYLAH R. ALFONSO AND LOGAN BREED JUNE 30 -JULY 6, 2014 PATENTS Court Approves 24.3 Million in Attorneys' Fees in Pay-For- Delay Litigation On June 30, a federal judge in Tennessee issued an
More informationHuawei v ZTE No More Need To Look At The Orange Book In SEP Disputes
1 Huawei v ZTE No More Need To Look At The Orange Book In SEP Disputes By James Killick & Stratigoula Sakellariou 1 (White & Case) September 2015 Industry standards are crucial for economic development
More informationClarifying Competition Law: Interface between Intellectual Property Rights and EU/U.S. Competition/Antitrust Law. Robert S. K.
Clarifying Competition Law: Interface between Intellectual Property Rights and EU/U.S. Competition/Antitrust Law Robert S. K. Bell Arindam Kar Speakers Robert S. K. Bell Partner Bryan Cave London T: +44
More informationFRAND or Foe: Litigating Standard Essential Patents
FRAND or Foe: Litigating Standard Essential Patents Munich Seminar May 2013 Munich, Germany Christopher Dillon (Dillon@fr.com) Jan Malte Schley (Schley@fr.com) Brian Wells (wells@fr.com) Presentation Overview
More informationCase 3:14-md WHO Document 1054 Filed 09/20/18 Page 1 of 6 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA
Case :-md-0-who Document 0 Filed 0/0/ Page of UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 0 0 In re LIDODERM ANTITRUST LITIGATION THIS DOCUMENT RELATES TO: DIRECT PURCHASER ACTIONS Case
More information5 Red Flags In Pharmaceutical Settlements
Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com 5 Red Flags In Pharmaceutical Settlements Law360,
More informationCase 3:14-md WHO Document Filed 07/31/18 Page 1 of 5
Case :-md-0-who Document 0- Filed 0// Page of 0 0 In re LIDODERM ANTITRUST LITIGATION THIS DOCUMENT RELATES TO: END-PAYOR PLAINTIFF ACTIONS UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA
More informationAntitrust IP Competition Perspectives
Antitrust IP Competition Perspectives Dr. Dina Kallay Counsel for IP and Int l Antitrust Federal Trade Commission The 6 th Annual Session of the UNECE Team of I.P. Specialists June 21, 2012 The views expressed
More informationFTC Orders Compulsory IP Licensing to Remedy Competitive Concerns in Honeywell/Intermec Transaction
SEPTEMBER 8-15, 2013 WRITTEN BY MAC CONFORTI AND LOGAN BREED MERGERS & ACQUISITIONS FTC Orders Compulsory IP Licensing to Remedy Competitive Concerns in Honeywell/Intermec Transaction The FTC required
More informationCourt in Microsoft v. Motorola Dismisses Injunctive Relief for Motorola Asserted Patents and Motorola s Entire H.264 SEP Portfolio
DECEMBER 3-7, 2012 WRITTEN BY KOREN W. WONG-ERVIN PATENTS Court in Microsoft v. Motorola Dismisses Injunctive Relief for Motorola Asserted Patents and Motorola s Entire H.264 SEP Portfolio In Microsoft
More informationLaw in the Global Marketplace: Intellectual Property and Related Issues FRAND Commitments and Obligations for Standards-Essential Patents
Law in the Global Marketplace: Intellectual Property and Related Issues FRAND Commitments and Obligations for Standards-Essential Patents Hosted by: Methodological Overview of FRAND Rate Determination
More informationNon-challenge clauses in the TTBER and beyond: implications for litigation and settlements. Sophie Lawrance, Senior Associate Bristows LLP 8 May 2015
Non-challenge clauses in the TTBER and beyond: implications for litigation and settlements Sophie Lawrance, Senior Associate Bristows LLP 8 May 2015 Agenda Brief review of the evolution of the law The
More informationCase5:12-cv RMW Document41 Filed10/10/12 Page1 of 10
Case:-cv-0-RMW Document Filed0/0/ Page of 0 E-FILED on 0/0/ 0 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION REALTEK SEMICONDUCTOR CORPORATION, v. Plaintiff,
More informationIntellectual Ventures Wins Summary Judgment to Defeat Capital One s Antitrust Counterclaims
Intellectual Ventures Wins Summary Judgment to Defeat Capital One s Antitrust Counterclaims News from the State Bar of California Antitrust, UCL and Privacy Section From the January 2018 E-Brief David
More informationIntellectual Property Rights and Antitrust Liability in the U.S.: The 2016 Landscape. Jonathan Gleklen Yasmine Harik Arnold & Porter LLP
Intellectual Property Rights and Antitrust Liability in the U.S.: The 2016 Landscape Jonathan Gleklen Yasmine Harik Arnold & Porter LLP June 2016 Perhaps the most fundamental question that arises at the
More informationPharmaceutical Patent Settlement Cases: Mixed Signals for Settling Patent Litigation
By Margaret J. Simpson Tel: 312 923-2857 Fax: 312 840-7257 E-mail: msimpson@jenner.com The following article originally appeared in the Spring 2004 issue of the Illinois State Bar Association s Antitrust
More informationJanuary 3, General Comments
COMMENT OF THE GLOBAL ANTITRUST INSTITUTE, GEORGE MASON UNIVERSITY SCHOOL OF LAW, ON THE KOREA FAIR TRADE COMMISSION S AMENDMENT TO ITS REVIEW GUIDELINES ON UNFAIR EXERCISE OF INTELLECTUAL PROPERTY RIGHTS
More informationFTC Commissioner Ohlhausen Recommends Cautious Treatment of Bosch and Google SEP Decisions
WRITTEN BY BRADLEY T. TENNIS AND KOREN W. WONG-ERVIN MARCH 18-22, 2013 PATENTS FTC Commissioner Ohlhausen Recommends Cautious Treatment of Bosch and Google SEP Decisions Last week, speaking at a symposium
More informationDOJ and USPTO Issue Policy Statement on Remedies for F/RAND-Encumbered SEPs
JANUARY 7-11, 2013 THIS WEEK S CONTRIBUTING AUTHOR IS DINA KALLAY EDITED BY KOREN W. WONG-ERVIN PATENTS DOJ and USPTO Issue Policy Statement on Remedies for F/RAND-Encumbered SEPs On January 8, the DOJ
More informationCOMMENT ON THE CANADIAN COMPETITION BUREAU S DRAFT UPDATED INTELLECTUAL PROPERTY ENFORCEMENT GUIDELINES
COMMENT ON THE CANADIAN COMPETITION BUREAU S DRAFT UPDATED INTELLECTUAL PROPERTY ENFORCEMENT GUIDELINES Joshua D. Wright George Mason University School of Law Douglas H. Ginsburg George Mason University
More informationR U T G E R S U N I V E R S I T Y L A W R E V I E W
R U T G E R S U N I V E R S I T Y L A W R E V I E W VOLUME 67 SPRING 2015 ISSUE 3 FOREWORD AFTER ACTAVIS: SEVEN WAYS FORWARD Michael A. Carrier * The Supreme Court s decision in FTC v. Actavis is one of
More informationCOMMENT OF THE GLOBAL ANTITRUST INSTITUTE, GEORGE MASON UNIVERSITY SCHOOL OF LAW, ON THE STATE ADMINISTRATION FOR INDUSTRY
COMMENT OF THE GLOBAL ANTITRUST INSTITUTE, GEORGE MASON UNIVERSITY SCHOOL OF LAW, ON THE STATE ADMINISTRATION FOR INDUSTRY AND COMMERCE ANTI-MONOPOLY GUIDELINES ON THE ABUSE OF INTELLECTUAL PROPERTY RIGHTS
More informationAssistant Attorney General Makan Delrahim Signals Shift in Antitrust/IP Focus
Antitrust Alert December 4, 2017 Key Points Assistant Attorney General (AAG) Makan Delrahim, the new head of the Antitrust Division of the Department of Justice (DOJ), recently announced a shift from the
More informationTHE TROUBLING USE OF ANTITRUST TO REGULATE FRAND LICENSING
THE TROUBLING USE OF ANTITRUST TO REGULATE FRAND LICENSING Douglas H. Ginsburg George Mason University School of Law Koren W. Wong-Ervin George Mason University School of Law Joshua D. Wright George Mason
More informationCOMMENT ON THE NATIONAL DEVELOPMENT AND REFORM COMMISSION S QUESTIONNAIRE ON INTELLECTUAL PROPERTY MISUSE ANTITRUST GUIDELINES
COMMENT ON THE NATIONAL DEVELOPMENT AND REFORM COMMISSION S QUESTIONNAIRE ON INTELLECTUAL PROPERTY MISUSE ANTITRUST GUIDELINES Douglas H. Ginsburg George Mason University School of Law Bruce H. Kobayashi
More informationCOMMENT OF UNITED STATES FEDERAL TRADE COMMISSIONER JOSHUA D. WRIGHT AND JUDGE DOUGLAS H
COMMENT OF UNITED STATES FEDERAL TRADE COMMISSIONER JOSHUA D. WRIGHT AND JUDGE DOUGLAS H. GINSBURG ON THE JAPAN FAIR TRADE COMMISSION S DRAFT PARTIAL AMENDMENT TO THE GUIDELINES FOR THE USE OF INTELLECTUAL
More information2 Noerr-Pennington Rulings Affirm Narrow Scope Of Immunity
Portfolio Media. Inc. 111 West 19 th Street, 5th Floor New York, NY 10011 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com 2 Noerr-Pennington Rulings Affirm Narrow
More informationFTC Approves Final Order in Google SEP Investigation, Responding to Commentators in a Separate Letter
WRITTEN BY BRENDAN J. COFFMAN AND KOREN W. WONG-ERVIN JULY 22-26, 2013 PATENTS FTC Approves Final Order in Google SEP Investigation, Responding to Commentators in a Separate Letter Last week, in a 2-1-1
More informationFinal Exam: The final exam is scheduled for May 8 at 6:00 PM. There is no make up exam.
Antitrust II (Spring 2018) Judge Douglas H. Ginsburg Professor of Law Antonin Scalia Law School at George Mason University Office: 450 I E mail: dginsbur@gmu.edu Welcome to Antitrust II This course examines
More informationIntellectual Property and Antitrust Seminar (Fall 2017)
Intellectual Property and Antitrust Seminar (Fall 2017) Darren S. Tucker 202-739-5740 / darrentucker20817@gmail.com Office Hours: By appointment (also available to answer questions via e-mail and phone)
More informationCase 1:10-cv JCJ Document 20 Filed 04/14/10 Page 1 of 12 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 110-cv-00137-JCJ Document 20 Filed 04/14/10 Page 1 of 12 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE MILLENNIUM PHARMACEUTICALS, INC. and SCHERING CORP., Plaintiffs, CIVIL ACTION
More informationThe ECJ s Huawei v. ZTE Decision and its Implementation in Practice
The ECJ s Huawei v. ZTE Decision and its Implementation in Practice Prof. Dr. Christian Donle, Attorney at Law Dr. Axel Oldekop, Attorney at Law December 2015 Overview I. Introduction II. III. The ECJ
More informationCPI Antitrust Chronicle March 2015 (1)
CPI Antitrust Chronicle March 2015 (1) Carte Blanche for SSOs? The Antitrust Division s Business Review Letter on the IEEE s Patent Policy Update Stuart M. Chemtob Wilson, Sonsini, Goodrich & Rosati www.competitionpolicyinternational.com
More informationSupreme Court of the United States
No. 15-1055 IN THE Supreme Court of the United States SMITHKLINE BEECHAM CORPORATION, D/B/A GLAXOSMITHKLINE; TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS, USA, Petitioners, v. KING DRUG COMPANY
More informationGLOBAL ANTITRUST INSTITUTE ECONOMICS INSTITUTE FOR COMPETITION ENFORCEMENT OFFICIALS
GLOBAL ANTITRUST INSTITUTE ECONOMICS INSTITUTE FOR COMPETITION ENFORCEMENT OFFICIALS 15 20 NOVEMBER, 2015 GLOBAL ANTITRUST INSTITUTE ECONOMICS INSTITUTE FOR COMPETITION ENFORCEMENT OFFICIALS Sunday, 15
More informationafter hearing the Opinion of the Advocate General at the sitting on 20 November 2014, gives the following Judgment 1 This request for a preliminary ru
JUDGMENT OF THE COURT (Fifth Chamber) 16 July 2015 (*) (Competition Article 102 TFEU Undertaking holding a patent essential to a standard which has given a commitment, to the standardisation body, to grant
More informationUnited States District Court EASTERN DISTRICT OF TEXAS TYLER DIVISION
Case 6:11-cv-00441-MHS Document 304 Filed 01/13/14 Page 1 of 5 PageID #: 8335 United States District Court EASTERN DISTRICT OF TEXAS TYLER DIVISION ALLERGAN, INC. v. Cause No. 6:11-cv-441 Consolidated
More informationInjunctive Relief for Standard-Essential Patents
Litigation Webinar Series: INSIGHTS Our take on litigation and trial developments across the U.S. Injunctive Relief for Standard-Essential Patents David Healey Sr. Principal, Fish & Richardson Houston,
More informationFTC AND DOJ ISSUE JOINT REPORT REGARDING ANTITRUST ENFORCEMENT AND INTELLECTUAL PROPERTY RIGHTS
OF INTEREST FTC AND DOJ ISSUE JOINT REPORT REGARDING ANTITRUST ENFORCEMENT AND INTELLECTUAL PROPERTY RIGHTS Interesting and difficult questions lie at the intersection of intellectual property rights and
More informationPharmaceutical Product Improvements and Life Cycle Management Antitrust Pitfalls 1
Pharmaceutical Product Improvements and Life Cycle Management Antitrust Pitfalls 1 The terms product switching, product hopping and line extension are often used to describe the strategy of protecting
More informationCase 1:10-cv UNA Document 1 Filed 10/05/10 Page 1 of 20
Case 1:10-cv-00852-UNA Document 1 Filed 10/05/10 Page 1 of 20 Case 1:10-cv-00852-UNA Document 1 Filed 10/05/10 Page 2 of 20 4. Plaintiff Allergan Sales, LLC is a corporation organized and existing under
More informationAntitrust/Intellectual Property Interface Under U.S. Law
BEIJING BRUSSELS CHICAGO DALLAS FRANKFURT GENEVA HONG KONG LONDON LOS ANGELES NEW YORK SAN FRANCISCO SHANGHAI SINGAPORE SYDNEY TOKYO WASHINGTON, D.C. Antitrust/Intellectual Property Interface Under U.S.
More informationThe Korean Drug Approval-Patent Linkage System: A Comparison with the US Hatch-Waxman Act
FEBRUARY 2015 The Korean Drug Approval-Patent Linkage System: A Comparison with the US Hatch-Waxman Act Authors: Ki Young Kim, Hyunsuk Jin, Samuel SungMok Lee Pursuant to the implementation of the Korea-US
More informationDIRECT PURCHASERS STANDING TO SUE FOR WALKER PROCESS FRAUD IN RE: DDAVP DIRECT PURCHASER ANTITRUST LITIGATION
DIRECT PURCHASERS STANDING TO SUE FOR WALKER PROCESS FRAUD IN RE: DDAVP DIRECT PURCHASER ANTITRUST LITIGATION Rick Duncan Denise Kettleberger Melina Williams Faegre & Benson, LLP Minneapolis, Minnesota
More informationThe New IP Antitrust Licensing Guidelines' Silence On SEPs
Portfolio Media. Inc. 111 West 19 th Street, 5th Floor New York, NY 10011 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com The New IP Antitrust Licensing Guidelines'
More informationAugust 6, AIPLA Comments on Partial Amendment of Guidelines for the Use of Intellectual Property Under the Antimonopoly Act (Draft)
Person in Charge of the Partial Amendment of the IP Guidelines (Draft) Consultation and Guidance Office, Trade Practices Division Economic Affairs Bureau, Secretariat, Japan Fair Trade Commission Section
More informationSUMMIT LAW GROUP PLLC 315 FIFTH AVENUE SOUTH, SUITE 1000 SEATTLE, WASHINGTON Telephone: (206) Fax: (206)
The Honorable James L. Robart UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF WASHINGTON AT SEATTLE 1 1 1 1 MICROSOFT CORPORATION, a Washington corporation, v. Plaintiff, MOTOROLA, INC., and MOTOROLA
More informationNTT DOCOMO Technical Journal. Akimichi Tanabe Takuya Asaoka Katsunori Tsunoda Makoto Kijima. 1. Introduction
Essential Patent Rights Exercise Restriction NPE 1. Introduction Recent growth in patent transactions has been accompanied by increasing numbers of patent disputes, especially in the field of information
More informationPatents and Standards The American Picture. Judge Randall R. Rader U.S. Court of Appeals for the Federal Circuit
Patents and Standards The American Picture Judge Randall R. Rader U.S. Court of Appeals for the Federal Circuit Roadmap Introduction Cases Conclusions Questions An Economist s View Terminologies: patent
More informationInternational Trade Daily Bulletin
International Trade Daily Bulletin VOL. 14, NO. 187 SEPTEMBER 26, 2014 INTELLECTUAL PROPERTY This BNA Insights article by Hitomi Iwase, Tony Andriotis & Paul Dimitriadis examines the recent U.S. legal
More informationUNITED STATES INTERNATIONAL TRADE COMMISSION Washington, D.C. THIRD PARTY UNITED STATES FEDERAL TRADE COMMISSION S STATEMENT ON THE PUBLIC INTEREST
UNITED STATES INTERNATIONAL TRADE COMMISSION Washington, D.C. In the Matter of CERTAIN GAMING AND ENTERTAINMENT CONSOLES, RELATED SOFTWARE, AND COMPONENTS THEREOF Inv. No. 337-TA-752 THIRD PARTY UNITED
More informationIncreased Scrutiny of Reverse Payment Settlements: Recent Cases in E.D. of PA and 2nd Circuit Suggest Change May Be Ahead for Pharma Clients
Increased Scrutiny of Reverse Payment Settlements: Recent Cases in E.D. of PA and 2nd Circuit Suggest Change May Be Ahead for Pharma Clients By Francis P. Newell and Jonathan M. Grossman Special to the
More informationPublished by. Yearbook. Building IP value in the 21st century. Standard-essential patent monetisation and enforcement. Vringo, Inc David L Cohen
Published by Yearbook 2016 Building IP value in the 21st century Standard-essential patent monetisation and enforcement Vringo, Inc David L Cohen Vringo, Inc Monetisation and strategy X X Standard-essential
More informationCase 1:09-cv UNA Document 1 Filed 07/13/2009 Page 1 of 17
Case 1:09-cv-00511-UNA Document 1 Filed 07/13/2009 Page 1 of 17 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE ALLERGAN, INC., ALLERGAN USA, INC., ALLERGAN SALES, LLC, ENDO PHARMACEUTICALS
More informationSTANDARD SETTING AND ANTITRUST: SSOs, SEPs, F/RAND AND THE PATENT HOLDUP. Jeffery M. Cross Freeborn & Peters LLP
STANDARD SETTING AND ANTITRUST: SSOs, SEPs, F/RAND AND THE PATENT HOLDUP By Jeffery M. Cross Freeborn & Peters LLP Standards and standard setting have been thrust recently to the forefront of antitrust
More informationIntellectual Property and Section 90.1 of the Competition Act
Intellectual Property and Section 90.1 of the Competition Act CBA Competition Law Spring Forum 2011 Ariel Katz Associate Professor University of Toronto Faculty of Law Can s. 90.1 start greater IP scrutiny?
More informationRecent Trends in Patent Damages
Recent Trends in Patent Damages Presentation for The Austin Intellectual Property Law Association Jose C. Villarreal May 19, 2015 These materials reflect the personal views of the speaker, are not legal
More informationthe Patent Battleground:
The Antitrust Enforcers Charge Onto the Patent Battleground: What Technology Companies Need to Know About Standard-Related Patents, RAND Commitments, and Competition Law Presenters: Willard K. Tom John
More informationAIPLA Comments on Questionnaire on IP Misuse Antitrust Guidelines
October 14, 2015 2015 10 14 Mr. Liu Jian Price Supervision and Anti-Monopoly Bureau National Development and Reform Commission People s Republic of China Re: AIPLA Comments on Questionnaire on IP Misuse
More informationPatents, Standards and Antitrust: An Introduction
Patents, Standards and Antitrust: An Introduction Mark H. Webbink Senior Lecturing Fellow Duke University School of Law Nature of standards, standards setting organizations, and their intellectual property
More informationIn the Supreme Court of the United States
No. 15-1055 In the Supreme Court of the United States SMITHKLINE BEECHAM CORPORATION, D/B/A GLAXOSMITHKLINE, ET AL., PETITIONERS v. KING DRUG COMPANY OF FLORENCE, INC., ET AL. ON PETITION FOR A WRIT OF
More informationOverview of Developments in Telecoms Patent Litigation
Fordham IP Conference April 2012 Overview of Developments in Telecoms Patent Litigation Ari Laakkonen Powell Gilbert LLP Health Warning: My comments reflect my personal opinions. 1992 Analogue phones were
More informationPharmaceutical Pay for Delay Settlements
Pharmaceutical Pay for Delay Settlements UCIP Seminar 12 November 2012 www.morganlewis.com Outline Background Goals of the Hatch-Waxman Act Price Effects of Generic Entry Pay-for-Delay Patent Settlements
More informationPAYING FOR DELAY AND THE RULE OF REASON FEDERAL TRADE COMMISSION V ACTAVIS INC ET AL 1
COMPETITION LAW PAYING FOR DELAY AND THE RULE OF REASON FEDERAL TRADE COMMISSION V ACTAVIS INC ET AL 1 LIGIA OSEPCIU 2 JUNE 2013 On 17 June 2013, the Supreme Court of the United States handed down its
More informationA Response to Chief Justice Roberts: Why Antitrust Must Play a Role in the Analysis of Drug Patent Settlements
A Response to Chief Justice Roberts: Why Antitrust Must Play a Role in the Analysis of Drug Patent Settlements Michael A. Carrier* The Supreme Court s decision in FTC v. Actavis, Inc. 1 has justly received
More informationPatent Hold-Up: Down But Not Out
Antitrust, Vol. 29, No. 3, Summer 2015. 2015 by the American Bar Association. Reproduced with permission. All rights reserved. This information or any portion thereof may not be copied or disseminated
More informationAIPLA Comments on the JPO Guide on Licensing Negotiations Involving Standard Essential Patents of March 9, 2018.
VIA EMAIL: PA0A00@jpo.go.jp Legislative Affairs Office General Coordination Division Policy Planning and Coordination Department Japan Patent Office 3-4-3 Kasumigaseki Chiyoda-ku Tokyo 100-8915, Japan
More informationDistrict Court Denies Motion to Dismiss FTC Section 5 Complaint Against Qualcomm
CPI s North America Column Presents: District Court Denies Motion to Dismiss FTC Section 5 Complaint Against Qualcomm By Greg Sivinski 1 Edited by Koren Wong-Ervin August 2017 1 Early this year, the US
More informationNos , -1631, -1362, UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT ERICSSON, INC. and TELEFONAKTIEBOLAGET LM ERICSSON,
Case: 13-1625 Case: CASE 13-1625 PARTICIPANTS Document: ONLY 162 Document: Page: 1 150 Filed: Page: 03/12/2014 1 Filed: 02/27/2014 Nos. 2013-1625, -1631, -1362, -1633 UNITED STATES COURT OF APPEALS FOR
More informationReverse Payment Settlements In Pharma Industry: Revisited
Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Reverse Payment Settlements In Pharma Industry: Revisited
More informationFrom PLI s Program New Strategies Arising from the Hatch-Waxman Amendments #4888
From PLI s Program New Strategies Arising from the Hatch-Waxman Amendments #4888 New Strategies Arising From the Hatch-Waxman Amendments Practicing Law Institute Telephone Briefing May 12, 2004 I. INTRODUCTION
More informationFrom Walker Process to In re DDAVP: Should Direct Purchasers Have Antitrust Standing in Walker Process Claims?
NOVEMBER 2008, RELEASE TWO From Walker Process to In re DDAVP: Should Direct Purchasers Have Antitrust Standing in Walker Process Claims? Aidan Synnott Paul, Weiss, Rifkind, Wharton & Garrison LLP From
More informationWHY THE SUPREME COURT WAS CORRECT TO DENY CERTIORARI IN FTC V. RAMBUS
WHY THE SUPREME COURT WAS CORRECT TO DENY CERTIORARI IN FTC V. RAMBUS Joshua D. Wright, George Mason University School of Law George Mason University Law and Economics Research Paper Series 09-14 This
More informationUNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA
0 0 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA IN RE: QUALCOMM LITIGATION Case No.: -cv-00-gpc-mdd ORDER ON JOINT MOTION FOR DETERMINATION OF DISCOVERY DISPUTE PRESENTING PLAINTIFFS MOTION
More informationRespecting Patent Rights: Model Behavior for Patent Owners
IPO LITIGATION PRINCIPLES TASK FORCE: WHITE PAPER Revised: 03/06/2007 Part I. Introduction 2007 Intellectual Property Owners Association (IPO) Disclaimer: This paper is presented for discussion purposes
More informationReasonable Royalties After EBay
Portfolio Media, Inc. 648 Broadway, Suite 200 New York, NY 10012 www.law360.com Phone: +1 212 537 6331 Fax: +1 212 537 6371 customerservice@portfoliomedia.com Reasonable Royalties After EBay Monday, Sep
More informationGood-Faith licensing negotiation. March 2018 Masabumi Suzuki RIETI Graduate School of Law, Nagoya University
Good-Faith licensing negotiation March 2018 Masabumi Suzuki RIETI Graduate School of Law, Nagoya University Outline FRAND and good-faith negotiation Legal contexts Different Approaches to Restriction of
More informationCase 1:16-cv UNA Document 1 Filed 01/15/16 Page 1 of 13 PageID #: 1 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE
Case 1:16-cv-00015-UNA Document 1 Filed 01/15/16 Page 1 of 13 PageID #: 1 PROSTRAKAN, INC. and STRAKAN INTERNATIONAL S.á r.l., IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE v. Plaintiffs,
More informationSuture Express, Inc. v. Owens & Minor Distrib., Inc., 851 F.3d 1029 (10th Cir.)
Antitrust Law Case Summaries Coordinated Conduct Case Summaries Prosterman et al. v. Airline Tariff Publishing Co. et al., No. 3:16-cv-02017 (N.D. Cal.) Background: Forty-one travel agents filed an antitrust
More informationThe Patented Medicines (Notice of Compliance) Regulations: What patents are eligible to be listed on the register?
The Patented Medicines (Notice of Compliance) Regulations: What patents are eligible to be listed on the register? Edward Hore Hazzard & Hore 141 Adelaide Street West, Suite 1002 Toronto, ON M5H 3L5 (416)
More informationCaraco V. Novo Nordisk: Antitrust Implications
Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Caraco V. Novo Nordisk: Antitrust Implications Law360,
More informationOctober 2014 Volume 14 Issue 1
theantitrustsource www. antitr ustsource. com October 2014 Volume 14 Issue 1 Implementing the FRAND Commitment Janusz Ordover and Allan Shampine examine the economic goals of FRAND terms for licensing
More informationRe: In the Matter of Robert Bosch GmbH, FTC File No
The Honorable Donald S. Clark, Secretary Federal Trade Commission 600 Pennsylvania Avenue, NW Washington, DC 20580 Re: In the Matter of Robert Bosch GmbH, FTC File No. 121-0081 Dear Secretary Clark: The
More informationCPI Antitrust Chronicle October 2015 (2)
CPI Antitrust Chronicle October 2015 (2) HUAWEÏ v ZTE: Judicial Conservatism at the Patent-Antitrust Intersection Nicolas Petit University of Liège www.competitionpolicyinternational.com Competition Policy
More informationPay-for-Delay Settlements: Antitrust Violation or Proper Exercise of Pharmaceutical Patent Rights?
Pay-for-Delay Settlements: Antitrust Violation or Proper Exercise of Pharmaceutical Patent Rights? By Kendyl Hanks, Sarah Jacobson, Kyle Musgrove, and Michael Shen In recent years, there has been a surge
More informationThe Antitrust Review of the Americas 2017
The Antitrust Review of the Americas 2017 Published by Global Competition Review in association with Analysis Group Axinn, Veltrop & Harkrider LLP Baker & Hostetler LLP Baker & McKenzie LLP Bennett Jones
More informationON NOVEMBER 6, 2001, the U.S. Court of Appeals
21 Biotechnology Law Report 13 Number 1 (February 2002) Mary Ann Liebert, Inc. Brief Analysis of Recent Pharmaceutical/IP Decisions DAVID A. BALTO AMERICAN BIOSCIENCE, INC. V. THOMPSON 269 F.3D1077, 2001
More informationFebruary I. General Comments
The U.S. Chamber of Commerce and the American Chamber of Commerce in China Joint Comments to the State Administration of Industry and Commerce on the Guideline on Intellectual Property Abuse (Draft for
More informationCase 1:12-cv RBW Document 9 Filed 12/03/12 Page 1 of 6 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA
Case 1:12-cv-01936-RBW Document 9 Filed 12/03/12 Page 1 of 6 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA ENDO PHARMACEUTICALS INC., Plaintiff, v. Civil Action 12-1936 (RBW UNITED STATES FOOD
More informationRecent Decisions Provide Some Clarity on How Courts and Government Agencies Will Likely Resolve Issues Involving Standard-Essential Patents
Chicago-Kent Journal of Intellectual Property Volume 13 Issue 1 Article 4 9-1-2013 Recent Decisions Provide Some Clarity on How Courts and Government Agencies Will Likely Resolve Issues Involving Standard-Essential
More informationLooking Within the Scope of the Patent
Latham & Watkins Antitrust and Competition Practice Number 1540 June 25, 2013 Looking Within the Scope of the Patent The Supreme Court Holds That Settlements of Paragraph IV Litigation Are Subject to the
More information